Atrial Functional Mitral Regurgitation and Tricuspid Regurgitation
Clinical Phenotypes, Risk Factors, & Determinants of Outcome in Functional Mitral and Tricuspid Valve Regurgitation
Barts & The London NHS Trust
141 participants
Dec 1, 2023
OBSERVATIONAL
Conditions
Summary
A prospective, observational cohort study designed to identify clinical phenotypes and evaluate predictors \& outcomes of functional mitral and tricuspid valve regurgitation in patients with atrial fibrillation. Participant will under go: * Baseline echocardiography * Cpex Echocardiography * Blood test: BNP * 1 year follow up Echocardiography Participants will be stratified into three subgroups: * Atrial Functional MR * Atrial Functional TR * Mixed MR \& TR
Eligibility
Inclusion Criteria5
- Informed consent
- Age of 18 years or older
- Atrial fibrillation
- Moderate or severe atrial valve disease
- Adequate 2D echocardiography views including parasternal long axis, short axis, apical two chamber, apical three chamber and four chamber.
Exclusion Criteria3
- Unwilling or unable to give consent
- Left ventricular impairment (ejection fraction \< 50%).
- Primary/organic valve disease
Interventions
Ultrasound scan of the heart
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05920824